These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6146968)
1. Practical aspects of the use of beta-blockers in anxiety states: situational anxiety. James IM Postgrad Med J; 1984; 60 Suppl 2():19-25. PubMed ID: 6146968 [No Abstract] [Full Text] [Related]
2. Practical aspects of the use of beta-blockers in anxiety stress: morbid anxiety. Hallstrom C Postgrad Med J; 1984; 60 Suppl 2():26-8. PubMed ID: 6146969 [No Abstract] [Full Text] [Related]
3. Beta-blockade in anxiety. Peet M Postgrad Med J; 1984; 60 Suppl 2():16-8. PubMed ID: 6146967 [No Abstract] [Full Text] [Related]
4. Interesting uses of beta blockers (3): Beta blockers in anxiety. Ogborne WL Aust Fam Physician; 1981 Jun; 10(6):472-5. PubMed ID: 6116486 [No Abstract] [Full Text] [Related]
5. [Clinical application of beta-blockaders]. Offerhaus L Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242 [No Abstract] [Full Text] [Related]
6. Clinical experience with beta-blockers in consultant psychiatric practice. Hawkings JR Scott Med J; 1975 Nov; 20(6):294-8. PubMed ID: 4893 [No Abstract] [Full Text] [Related]
7. Beta-adrenergic blockers for anxiety. Med Lett Drugs Ther; 1984 Jun; 26(664):61-2. PubMed ID: 6145089 [No Abstract] [Full Text] [Related]
8. Plasma concentration and antihypertensive effect of beta-receptor blockers. Hitzenberger G Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485 [No Abstract] [Full Text] [Related]
10. Treating stage fright in musicians: the use of beta blockers. Lehrer PM; Rosen RC; Kostis JB; Greenfield D N J Med; 1987 Jan; 84(1):27-33. PubMed ID: 2883619 [No Abstract] [Full Text] [Related]
11. A dose-response study of propranolol in chronic schizophrenics. Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858 [No Abstract] [Full Text] [Related]
12. [Betadrenol influence on cardiovascular and metabolic behavior in oral surgery with local anesthesia]. Tetsch P; Brisse B; Eismann U Dtsch Zahnarztl Z; 1973 Oct; 28(10):1011-5. PubMed ID: 4148792 [No Abstract] [Full Text] [Related]
13. The use of beta-adrenergic blocking agents in anxiety disorders and schizophrenia. Hayes PE; Schulz SC Pharmacotherapy; 1983; 3(2 Pt 1):101-17. PubMed ID: 6134273 [TBL] [Abstract][Full Text] [Related]
14. [Interest of propranolol in the treatment of school refusal anxiety: about three clinical observations]. Fourneret P; Desombre H; de Villard R; Revol O Encephale; 2001; 27(6):578-84. PubMed ID: 11865565 [TBL] [Abstract][Full Text] [Related]
15. Treatment of anxiety states: some theoretical and practical aspects. Dennis JL; Hendrie HC J Indiana State Med Assoc; 1980 May; 73(5):300-5. PubMed ID: 6107320 [No Abstract] [Full Text] [Related]
17. Treatment of anxiety neurosis by alpha and beta adrenergic blocking agents. Penningroth RP; Steinmeyer CH J Iowa Med Soc; 1974 May; 64(5):205-7. PubMed ID: 4151149 [No Abstract] [Full Text] [Related]
18. Beta-adrenergic blocking drugs in anxiety. Silverstone T Scott Med J; 1975 Nov; 20(6):281-2. PubMed ID: 4884 [No Abstract] [Full Text] [Related]
19. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH). Békés M; Matos L; Rausch J; Török E Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774 [No Abstract] [Full Text] [Related]